SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-016546
Filing Date
2016-04-25
Accepted
2016-04-25 08:00:20
Documents
8
Period of Report
2016-06-06
Effectiveness Date
2016-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A bmrn-def14a_20160606.htm DEF 14A 2726951
2 GRAPHIC gutf041zgghs000002.jpg GRAPHIC 26379
3 GRAPHIC gutf041zgghs000003.jpg GRAPHIC 23167
4 GRAPHIC gutf041zgghs000005.jpg GRAPHIC 66477
5 GRAPHIC gutf041zgghs000007.jpg GRAPHIC 47335
6 GRAPHIC gutf041zgghs000001.jpg GRAPHIC 2264
7 GRAPHIC gutf041zgghs000004.jpg GRAPHIC 12125
8 GRAPHIC gutf041zgghs000006.jpg GRAPHIC 73240
  Complete submission text file 0001564590-16-016546.txt   3074617
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26727 | Film No.: 161587905
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1